The U.S. Food and Drug Administration approved a reduction in age from 1 year to 3 months for maralixibat (Livmarli; Mirum) oral solution for the treatment of cholestatic pruritus in patients with Alagille...

The clinical profile of patients with thyroid eye disease (TED) with high IgG4 and with normal IgG4 are different, leading researchers to believe this may be a marker of disease activity. More data...

  A delay in growth hormone replacement therapy (GHRT) after childhood-onset craniopharyngioma treatment is not associated with the risk of recurrence or tumor progression, according to a study. In this retrospective, observational, a...

This systematic review identified studies that compared lung ultrasound (LUS) with high-resolution computed tomography (HRCT) in the diagnosis of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). HRCT is considered standard...